October Technical Analysis

OP
EGS380R1C018 -- Egypt Stock  

 100.00  0.00  0.00%

Macroaxis technical analysis interface allows you to check existing technical drivers of October Pharma as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for October Pharma, which can be compared to its competitors. Please check October Pharma Information Ratio, Treynor Ratio, Value At Risk, as well as the relationship between Jensen Alpha and Maximum Drawdown to decide if October Pharma is priced some-what accurately providing market reflects its current price of 100.0 per share.

Search Technical Analysis

 
Refresh
October Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of October Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst, therefore, looks at the history of October Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

October Pharma Technical Analysis

Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

October Pharma Trend Analysis

Use this graph to draw trend lines for October Pharma. You can use it to identify possible trend reversals for October Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual October Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

October Pharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for October Pharma applied against its price change over selected period. The best fit line has a slop of   0.00  . It has 8 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted October Pharma price change compared to its average price change.

About October Pharma Technical Analysis

The Macroaxis Technical Analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of October Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of October Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on October Pharma stock first instead of the macroeconomic environment surrounding October Pharma. By analyzing October Pharma's financials, daily price indicators, and its related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of October Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to October Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.

October Pharma June 3, 2020 Technical Indicators

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Continue to Investing Opportunities. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page